MedPath

Wuhan Ammunition Life-tech Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma

Recruiting
Conditions
Urothelial Carcinoma
First Posted Date
2024-08-21
Last Posted Date
2024-08-21
Lead Sponsor
Wuhan Ammunition Life-tech Co., Ltd
Target Recruit Count
148
Registration Number
NCT06564363
Locations
🇨🇳

Peking University First Hospital, Beijing, China

Clinical Study of Pan-cancer DNA Methylation Test in Plasma

Recruiting
Conditions
Cancer
First Posted Date
2023-01-17
Last Posted Date
2023-01-17
Lead Sponsor
Wuhan Ammunition Life-tech Co., Ltd
Target Recruit Count
3000
Registration Number
NCT05685524
Locations
🇨🇳

The first affiliated hospital of Zhengzhou University, Zhengzhou, Henan, China

KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method)

Completed
Conditions
Esophageal Neoplasms
First Posted Date
2023-01-11
Last Posted Date
2024-02-13
Lead Sponsor
Wuhan Ammunition Life-tech Co., Ltd
Target Recruit Count
1116
Registration Number
NCT05680077
Locations
🇨🇳

The First Affiliated Hospital of Naval Military Medical University, Shanghai, China

GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescence PCR Method)

Not yet recruiting
Conditions
Hepatocellular Carcinoma
First Posted Date
2022-12-30
Last Posted Date
2022-12-30
Lead Sponsor
Wuhan Ammunition Life-tech Co., Ltd
Target Recruit Count
1000
Registration Number
NCT05668793

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.